Healthcare Third-party Logistics Market to Reach $431.3 Billion, Globally, by 2033 at 7.4% CAGR: Allied Market Research

The report includes the analysis of the regional as well as global healthcare third-party logistics market trends, key players, market segments

WILMINGTON, NEW CASTLE, DE, UNITED STATES, December 2, 2024 /EINPresswire.com/ -- The 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐓𝐡𝐢𝐫𝐝-𝐩𝐚𝐫𝐭𝐲 𝐋𝐨𝐠𝐢𝐬𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 was valued at $212.4 billion in 2023, and is estimated to reach $431.3 billion by 2033, growing at a CAGR of 7.4% from 2024 to 2033. Key drivers include the increase in demand for efficient logistics solutions due to growth in pharmaceutical and medical device markets, stringent regulatory requirements necessitating specialized handling, and the rise of biologics and temperature-sensitive products requiring advanced cold chain logistics. Restraints involve the high cost of implementing and maintaining compliance with complex regulations, the need for robust quality control measures, and security concerns regarding the transport of sensitive healthcare products.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 (𝐆𝐞𝐭 𝐅𝐮𝐥𝐥 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐢𝐧 𝐏𝐃𝐅 - 278 𝐏𝐚𝐠𝐞𝐬) 𝐚𝐭: https://www.alliedmarketresearch.com/request-sample/A324585

Opportunities abound in the adoption of advanced technologies such as internet of things (IoT) for real-time tracking, blockchain for supply chain transparency, and the expanding role of e-commerce in healthcare, which boosts demand for innovative last-mile delivery solutions. In addition, the push for sustainable logistics practices and the expansion of global healthcare supply chains presents significant growth prospects for the industry. 

Based on end user, pharmaceutical companies dominated the market in 2023 due to their substantial need for specialized logistics services to manage the complex distribution of a wide range of products, including high-value and temperature-sensitive medications. This segment's dominance is driven by the sheer volume of pharmaceuticals that require stringent regulatory compliance and reliable cold chain logistics. Meanwhile, the biotechnology companies' segment is expected to experience a significant growth, spurred by the increasing development and commercialization of biologics and personalized medicine. These products often demand highly specialized logistics solutions, such as precise temperature control and expedited delivery, to maintain their efficacy and safety, driving significant investment and innovation in biotech logistics. 

𝐁𝐮𝐲 𝐍𝐨𝐰 & 𝐆𝐞𝐭 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 : https://www.alliedmarketresearch.com/healthcare-third-party-logistics-market/purchase-options

By service type, the transportation service segment dominated the market in 2023, driven by the critical need to efficiently move pharmaceuticals, medical devices, and other healthcare products across various locations, ensuring timely and safe deliveries. However, the cold chain logistics service segment is expected to experience a significant growth due to the increasing demand for temperature-sensitive products such as biologics, vaccines, and specialty drugs, which require specialized storage and transportation solutions to maintain their efficacy and comply with stringent regulatory standards. This rapid growth is further fueled by advancements in cold chain technologies and the rising focus on maintaining product integrity throughout the supply chain. 

𝐓𝐡𝐞 𝐤𝐞𝐲 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐩𝐫𝐨𝐟𝐢𝐥𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞

DHL Supply Chain, Amerisource Burgen, Sinotrans, XPO logistics, Nippon Express, UPS Healthcare Logistics, Kerry Logistics Network Limited, CH Robinson Worldwide, DB Schenker, Barett Distribution, Kinesis Medical B.V., Expeditors International, Kuehne and Nagel, Cardinal Health, FedEx Supply Chain, Freight logistics Solutions, SF Express, AGILITY, United Parcel Service of America, Inc.

𝐆𝐞𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐰𝐢𝐭𝐡 𝐲𝐨𝐮’𝐫𝐞 𝐑𝐞𝐪𝐮𝐢𝐫𝐞𝐦𝐞𝐧𝐭𝐬: https://www.alliedmarketresearch.com/request-for-customization/A324585

By region, North America dominated the market in 2023, due to its advanced healthcare infrastructure, stringent regulatory standards, and high adoption of outsourcing practices in logistics. The region benefits from a well-established network of 3PL providers offering specialized services tailored to the healthcare sector's needs, including pharmaceuticals, medical devices, and biotechnology products. On the other hand, the Asia-Pacific region is expected to experience significant growth in the 3PL healthcare market. Factors driving this growth include the expanding pharmaceutical and biotech industries, increasing healthcare expenditures, and rising demand for efficient supply chain solutions across populous countries such as China and India. Moreover, regulatory reforms aimed at improving healthcare access and quality are further boosting the demand for 3PL services in the region. As a result, Asia-Pacific is becoming an increasingly important market for healthcare logistics, driven by its economic growth, expanding healthcare infrastructure, and evolving regulatory environment. 

𝐑𝐞𝐜𝐞𝐧𝐭 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬:

In an effort to better serve its worldwide healthcare and pharmaceutical clientele, CEVA Logistics launched a new sub-brand on July 04, 2021, in recognition of World Health Day. The company's comprehensive portfolio of healthcare logistics services aims to promote improved patient outcomes. The Ceva Forpatients sub-brand is the new brand for it. Ceva Forpatients provides comprehensive logistics solutions that prioritize the patient at the heart of the supply chain to healthcare and pharmaceutical enterprises. The company developed a new temperature-sensitive logistics product as part of the portfolio of solutions, and it started online in the second quarter of 2021. 

As per Nippon Express information published on June 06, 2022, Nippon Express Co., Limited, a Group company of Nippon Express Holdings, Inc. launched a logistics service capable of handling goods requiring ultra-low temperatures (-20°C to -85°C) for the pharmaceutical industry.  

As per the article published by J&T Express Middle East on May 17, 2023, a global logistics service provider, J&T Express entered into a share transfer agreement with Shenzhen Fengwang Holdings Company Limited, a subsidiary of S.F. Holding Company, Limited. J&T Express' subsidiary J&T Express (Shenzhen) Supply Chain Company, Limited. acquired 100% share rights of Fengwang Holding's wholly owned subsidiary, Shenzhen Fengwang Information Technology Company Limited. 

𝐈𝐧𝐪𝐮𝐢𝐫𝐲 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠: https://www.alliedmarketresearch.com/purchase-enquiry/A324585

The report provides a detailed analysis of these key players in the global healthcare third-party logistics market. These players have adopted different strategies such as new product launch, and agreement strategies to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.  

David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
X